Cardiovascular diseases

Video • Wearable for blood pressure, heart rate, glucose and more

New patch monitors multiple markers at once

Engineers at the University of California San Diego have developed a soft, stretchy skin patch that can be worn on the neck to continuously track blood pressure and heart rate while measuring the wearer’s levels of glucose as well as lactate, alcohol or caffeine. It is the first wearable device that monitors cardiovascular signals and multiple biochemical levels in the human body at the same…

News • On the go

Improving wearables for medical applications

Cardiovascular diseases are the most common cause of fatalities in Germany. Medical wearables which measure vital parameters such as the blood pressure, heart rate and blood oxygen levels in real time could help detect these diseases early, and treat them on a preventive basis. In daily life and during sports activities, in the form of fitness bracelets or smart watches, these small, portable…

News • Repairing heart muscle with stem cells

Trial run for tissue engineered 'heart patch'

For the first time, engineered heart muscle (EHM) from human induced pluripotent stem cells (iPSCs) will be used to treat patients with heart failure. After regulatory approval, recruitment of the first patient for the first-in-class, first-in-patient BioVAT-HF early clinical trial has started in Göttingen, Germany.

News • Prevention

High blood pressure causes atrial fibrillation

The first evidence from genetic data that high blood pressure is causally associated with the most common heart rhythm disorder is published in the European Journal of Preventive Cardiology, a journal of the European Society of Cardiology (ESC).

News • Coronavirus and the heart

Covid-19 infection raises risk of dying after a cardiac arrest

Covid-19 patients who suffer a cardiac arrest either in or out of hospital are far more likely to die than patients who are not infected with the coronavirus. In particular, women have the highest risk of dying: they are nine times more likely to die after suffering a cardiac arrest in hospital, according to research published in the European Heart Journal.

News • Promising alternative to heart transplants

'Artificial aorta' to reduce blood pressure

Engineers at EPFL’s Center for Artificial Muscles have developed a silicone aorta that can reduce how hard patients’ hearts have to pump. Their breakthrough could offer a promising alternative to heart transplants. “Over 23 million people around the world suffer from heart failure. The disease is usually treated with a transplant, but because donated hearts are hard to come by, there is an…

News • Heightened risk of major heart disease and stroke

Why is fried food bad for the heart?

Fried-food intake is linked to a heightened risk of major heart disease and stroke, finds a pooled analysis of the available research data, published online in the journal Heart. And the risk rises with each additional 114 g weekly serving, the analysis indicates. It’s clear that the Western diet doesn’t promote good cardiovascular health, but it’s not clear exactly what contribution fried…

News • Biodegradable implantables

One step closer to regenerative heart valves and stents

Non-degradable prostheses for cardiovascular tissues can be used to replace heart valves and blood vessels, but they can’t stay in the body permanently. In two recent papers, researchers at the Eindhoven University of Technology (TU/e) in collaboration with a number of clinical partners, the Dutch Heart Foundation, and TU/e spin-off companies Suprapolix, Xeltis, and STENTiT have shown how…

News • High-risk group

Covid-19 doubles death rate in acute heart failure patients

Patients with acute heart failure nearly double their risk of dying if they get Covid-19, according to new research. The small, single centre study highlights the need for patients with heart failure to take extra precautions to avoid catching Covid-19. “Our results support prioritising heart failure patients for Covid-19 vaccination once it is available,” said study lead investigator Dr.…

News • Atrial fibrillation treatment

Gold-tipped, force sensing ablation catheter approved for CE-market

Electrophysiologists in Europe will now have access to state-of-the-art, gold-tipped force sensing ablation catheters following the Biotronik announcement that AlCath Force is CE-market approved. With the release of the unique catheter, a full suite of specialized tools for a complete solution in the treatment of complex atrial fibrillation (AF) cases is available to physicians.

News • Machine learning

AI performs similar to traditional risk prediction models

A study published by The BMJ finds that machine learning models have similar performance to traditional statistical models and share similar uncertainty in making risk predictions for individual patients.

News • Cardiovascular Magnetic Resonance

Insight on the use of CMR in COVID-19 patients

The Society for Cardiovascular Magnetic Resonance (SCMR), a Society dedicated to improving cardiovascular health by advancing the field of cardiovascular magnetic resonance (CMR), has released a formal statement supporting and explaining their position on the use of CMR in COVID-19 patients. The topic has led to debate among medical professionals, especially those in the cardiology specialty.

Article • Non-pulmonary aspects

The cardiovascular impact of Covid-19

The increased Covid-19 risk to cardiac patients was discussed during an online presentation at ECR 2020. Focusing on the prevalence of pulmonary embolism in Covid-19 patients, Dr Karl-Friedrich Kreitner, Professor of Radiology at the Department of Diagnostic and Interventional Radiology at the Johannes-Gutenberg University in Mainz, Germany, discussed hypotheses which can explain cardiac…

Article • Entering a new age

AI predicts blood flow to the heart

Artificial Intelligence (AI) has, for the first time, measured blood flow to the heart to help predict which patients may suffer myocardial infarction or stroke. A research team at University College London and Barts Health NHS Trust and the National Institutes for Health (NIH) in the USA – are optimistic that AI analysis of perfusion maps will be a reliable, convenient and detailed new…

Article • Vasovagal faint

Study findings set to offer new benefit for fainting patients

Researchers hope combining a dual-chamber pacemaker with a Closed Loop Stimulation algorithm could lead to a change of emphasis in clinical practice and help reduce unexplained fainting in more patients with recurrent episodes due to skipped heartbeats.

Remote cardiac monitoring

For cardiology patients fitted with an implantable cardiac monitor, cardioverter defibrillator (ICD) or pacemaker, home monitoring is a blessing. The system also has many advantages for medical staff, as Kristina Rauholt reports. The nurse and Certified Cardiac Device Specialist for Allied Professionals (CCDS) at the Sahlgrenska University Hospital, in Sweden, has worked with home monitoring…

Article • Cardiovascular risk

Cholesterol drug combination could benefit heart patients

A new study has suggested that more patients could benefit from combinations of cholesterol-lowering drugs to reduce their risk of stroke and heart attacks. While risk is reduced for many patients through taking statins, those at the highest risk of cardiovascular events may benefit from combinations of lipid-lowering therapies, according to the results of a European study of patients across 18…

News • Atrial fibrillation ablation

Superfast procedure to treat heart arrhythmia

A new procedure to correct atrial fibrillation (AF) has been performed for the first time in the UK last week at Leicester's Hospitals. AF affects 1-2% of the general population, which amounts to more than 1 million people in the UK, and increases the risk of stroke by five times. Treating the condition with medicine is often ineffective, with many patients continuing to suffer from…

News • Facial photo analysis

AI uses ‘selfies’ to detect heart disease

Sending a “selfie” to the doctor could be a cheap and simple way of detecting heart disease, according to the authors of a new study. The study is the first to show that it’s possible to use a deep learning computer algorithm to detect coronary artery disease (CAD) by analysing four photographs of a person’s face. Although the algorithm needs to be developed further and tested in larger…

News • L-type calcium channel blockers

LCCBs may contribute to heart failure

L-type calcium channel blockers (LCCBs) — the most widely used drugs for treating hypertension — may harm the heart as much as help it, according to a new study. The research team, led by the Pennsylvania State University, found that in rats and human cells in vitro, LCCBs cause changes in blood vessels — known as vascular remodeling — that reduce blood flow and increase pressure.…

News • 3D microprinted scope

World’s smallest imaging device focuses on heart disease

A team of researchers led by the University of Adelaide and University of Stuttgart has used 3D micro-printing to develop the world’s smallest, flexible scope for looking inside blood vessels. The camera-like imaging device can be inserted into blood vessels to provide high quality 3D images to help scientists better understand the causes of heart attack and heart disease progression, and could…

News • Surprising find

More than half of heart scans abnormal in hospitalised COVID-19 patients

Half of COVID-19 patients who received a heart scan in hospital showed abnormalities in heart function, according to new research funded by the British Heart Foundation (BHF). The study, published in the European Heart Journal - Cardiovascular Imaging, found that around one in seven showed severe abnormalities likely to have a major effect on their survival and recovery. It also showed that one…

News • 30 years after reunification, health disparities still exist

Germany: reunited but still divided (in healthcare)

East Germany has many more hospitalisations for heart failure compared to West Germany despite a nationwide healthcare system, according to research presented today on HFA Discoveries, a scientific platform of the European Society of Cardiology (ESC). Heart failure is the most common reason for hospital admissions and is responsible for a large part of the total health expenditure on…

Interview • Abbott cardiovascular

An increasingly dynamic cardiovascular presence

In the world of laboratory diagnostics, ‘Abbott’ is a household name. Few people however are aware of the fact that the company, headquartered in Illinois, USA, is also leading in other fields. A number of innovations in cardiac and vascular diagnostics and therapy might soon put Abbott in the limelight. Dr Angela Germer, Regional Director DACH, and Volker Keller, Head of Marketing DACH,…

News • Teaching partnership

Setting new standards for specialist integrated cardiac care

Royal Philips and Leeds Teaching Hospitals NHS Trust announced a seven-year managed service agreement to deliver on the Trusts’ vision to set new standards of excellence for cardiac care in the UK and globally. The partnership will combine the latest innovations in technology for integrated cardiovascular solutions to deliver on the quadruple aim: better health outcomes, lower cost of care, and…

545 show more articles